seroconversion
英
美
网络 血清阳转; 血清转换; 血清转化; 血清转阳现象; 血清学转换
BNC.31262
双语例句
- Objective To investigate the seroconversion rate of antibody after rabies vaccine inoculation and the its related factors.
目的探讨接种狂犬病疫苗后抗体阳转率及其相关因素。 - Patients cycled between the following health states: viral suppression, ongoing viremia, seroconversion, hepatocellular carcinoma, cirrhosis and death.
乙肝患者经历以下的疾病状态：病毒抑制、病毒血症期、血清转化、肝细胞癌、肝硬化和死亡。 - The end point of a new therapy is to decline, decrease viremia and to achieve the antigen seroconversion.
治疗终点就是要降低病毒血症，然后获得抗原的血清转化。 - PRRSV seroconversion and viremia typically occur during the nursery phase of production.
PRRS毒血清转换和毒血症通常发生在生产育苗阶段。 - Anti-HAV seroconversion rate reached more than 80.00% 1~ 2 months after inoculation.
免后1～2个月的抗-HAV阳转率均达80%以上。 - There were significant differences in the HBeAg sero-conversion rate and HBV DNA seroconversion rate between the 2 groups.
2组间HBeAg阴转率和HBVdna阴转率有显著性差异。 - Objective: To investigate the HIV seroconversion and cohort retention in a 2-year follow-up study among injection drug users ( IDUs).
目的：了解静脉吸毒人群前瞻性队列研究2年随访的HIV血清抗体阳转率和保持率情况。 - The seroconversion rate of HI antibody for type A 1, type A 3 and type B influenza was 97.7%, 99.2% and 82.9% respectively. The GMT of vaccination group was much higher than that of the control group.
A1、A3、B型的血凝抑制抗体阳转率分别为97.7%、99.2%和82.9%，接种组GMT均明显高于对照组。 - The results showed that the rates of ALT recovery, HBeAg negative conversion and clinical effect were positive related to the inflammation grades, and the HBV DNA negative conversion rate and HBeAg/ anti-HBe seroconversion rate were not related to it.
ALT复常率、HBeAg阴转率、临床疗效与肝脏炎症活动度呈正相关，HBVdna阴转率、HBeAg/抗HBe血清转换率与肝脏炎症活动度无关。 - Anti HBs positive seroconversion rate was 78.13% ( 493/ 631).
调查合格接种乙肝疫苗儿童631人，抗-HBs阳性493人，抗-HBs阳转率为78.13%。 - Conclusion: The HBeAg seroconversion in some patients was resulted possibly by HBV genovariation, and the replication of HBV DNA of those patients still existed high level.
结论：部分HBeAg发生血清转换的患者可能是HBV基因变异所致，其HBVdna仍可呈现高水平复制，因此血清标志物指标需结合病毒载量一起分析才能得出更可靠的结论。 - The seroconversion rates were 82%, 100% and 94.2% respectively.
4年时抗体阳转率分别为82%、100%和94.2%。 - In some patients with HBeAg seroconversion, there are still active HBV replication and liver damage.
如出现了HBeAg的血清转换，但仍有乙肝病毒的活跃复制和肝脏的损伤，则病人属HBeAg阴性慢性乙肝。 - After HBeAg seroconversion, the disease become remission.
如出现了HBeAg血清学转换，常伴有病情的缓解。 - After treatment serum ALT, the seroconversion rate of HBV-DNA and HBeAg in two groups were detected respectively and untoward reaction were observed.
观察患者血清ALT的变化、HBV-DNA和HBeAg阴转率以及用药后的不良反应。 - Result: After 9 months of treatment, the treatment group was superior to the control group in the negative seroconversion rate of HBsAg, HBeAg and HBV DNA, the recovery rate of liver function, symptoms and signs.
结果：治疗9个月后，治疗组在HBsAg、HBeAg、HBVdna阴转率，肝功能复常率及症状体征的恢复率方面优于对照组。 - After purification of S79 mumps virus strain by the plaque method, the seroconversion rate can raise to94%.
该毒株经蚀斑纯化后，其疫苗的抗体阳转率可提高至94%。 - RESULTS Significant differences were found between the 2 groups in the liver function change, HBeAg and HBV DNA loss or seroconversion and the survival rate.
结果治疗组在改善肝功能及HBeAg和HBVdna阴转率及提高存活率诸方面较对照组有显著性差异。 - Results Normalization rate of hepatic function, HBV DNA seroconversion rate and HBeAg/ HBeAb seroconversion rate in two treatment groups were significantly higher than those in control group.
结果治疗组A和治疗组B的HBVdna阴转率和HBeAg/HBeAb转换率均明显高于对照组。 - HBeAg/ anti-HBe seroconversion was not a turning point from replicative to nonreplicative phase of the virus.
HBeAg/抗-HBe血清转换不是病毒复制与非复制时相的截然转折点。 - Durability of seroconversion after long-term lamivudine therapy in HBeAg positive chronic hepatitis B patients
拉米夫定治疗HBeAg阳性慢性乙型肝炎患者血清转换持久性的研究 - Animal subjects could produce satisfactory immune response after recombinant virus 'induction. Both intramuscular injection and intraperitoneal injection could induce the production of antilyssic neutralizing antibodies. The seroconversion rates were respectively 6.7% and 86.7%.
结果显示，该重组病毒可以诱导机体产生良好的体液免疫应答，肌肉和腹腔注射均可使部分小鼠产生抗狂犬病的中和抗体，其阳转率分别为6.7%和86.7%。 - Observation of two pairs e antigen seroconversion and virological indicators found that the treatment group compared with the control group, HBeAg and HBV-DNA negative conversion overcast was no significant difference.
在观察两组对e抗原血清学转换和病毒学指标时发现，两组HBeAg阴转和HBV-DNA阴转差异均无统计学意义。 - The rate of disappear of HBsAg or the incidence of seroconversion in children with chronic hepatitis B using lamivudine antiviral therapy may be more common than that in adults. It needs further study.
儿童慢性乙型肝炎使用拉米夫定抗病毒治疗出现HBsAg消失或血清学转换的发生率可能比成人治疗后多见，有待进一步研究。